CD8A and neoplasm: For instance, combining PD-1 blockade with pegylated interferon-α (Peg-IFNα) has been shown to increase cytotoxic CD8+ T-cell infiltration, restore anti-tumor immunity, promote tumor cell apoptosis, and reduce angiogenesis in HCC models (46).